Company: ENTXW
Filing Date: 2025-05-30
Form Type: S-3
Source: 0001178913-25-002025
Chunk: 25

Company: Entera Bio Ltd.
Filing Date: 2025-05-30
Form: S-3
Chunk 25
---
 to a prospectus supplement; |

| • | ordinary brokerage transactions and transactions in which a broker-dealer solicits purchasers; |

| • | sales “at the market”, within the meaning of Rule 415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise; or |

| • | sales in other ways not involving market makers or established trading markets, including direct sales to purchasers. |

The prospectus supplement will state the terms of the offering of the securities, including:

| • | the name or names of any underwriters, dealers or agents; |

| • | the purchase price of such securities and the proceeds to be received by us, if any; |

| • | any underwriting discounts or agency fees and other items constituting underwriters’ or agents’ compensation; |

| • | any initial public offering price; |

| • | any discounts or concessions allowed or reallowed or paid to dealers; and |

| • | any securities exchanges on which the securities may be listed. |

Any initial public offering price and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time. If underwriters are used in the sale, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions, including:

| • | negotiated transactions; |

| • | at a fixed public offering price or prices, which may be changed; |

| • | at market prices prevailing at the time of sale; |

| • | at prices related to prevailing market prices; or |

| • | at negotiated prices. |

19 Unless otherwise stated in a prospectus supplement, the obligations of the underwriters to purchase any securities will be conditioned on customary closing conditions and the underwriters will be obligated to purchase all of such series of securities, if any are purchased. The securities may be sold through agents from time to time. The prospectus supplement will name any agent involved in the offer or sale of the securities and any commissions paid to them. Generally, any agent will be acting on a best efforts basis for the period of its appointment. Sales to or through one or more underwriters or agents in at-the-market offerings will be made pursuant to the terms of a distribution or sales agreement with the underwriters or agents. Such underwriters or agents may act on an agency basis or on a principal basis. During the term of any such agreement, shares may be sold on